Veenstra, J.

patient mutation hiv -2-infected patients therapy resistance antiretroviral regimen hiv -2 -2-infected hiv -2 consensus antiretroviral therapy group study virus plasma suppression protease van der ende inhibitor infection 500 copies /ml table combination group i group ii netherland immunodeficiency treatment 2-5 individual month hiv -2 protease indinavir 90 m mutation virological hiv -1-infected patients los alamos database range hiv -2-rna suppression transcriptase hiv -2-infected individuals response position -2-rna nucleoside result pi resistance zidovudine follow-up trial consensus primer 151 m mutation zdv zidovudine virological response osterhaus ad department q 151m mutation baseline antiretroviral drug resistance transcriptase inhibitors count failure ritonavir hospital prot gene idv plasma levels van laethem k antiretroviral drugs hiv -2 suppression immunodeficiency virus infection detection sequence nucleoside analogues level rotterdam rt protein 4t stavudine 2-19 limit